Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: Evidence for a secretion into cystic fluid

European Journal of Endocrinology

Volumn 141, Issue 2, 1999, Pages 190-194

  Di Loreto, C ^a   Reis, F M ^a   Cataldi, P ^a   Zuiani, C ^a   Luisi, S ^a   Beltrami, C A ^a   Petraglia, F ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; INHIBIN; PROTEIN SUBUNIT; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYST FLUID; FEMALE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MAMMARY GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ACTIVINS; BODY FLUIDS; BREAST; BREAST NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; FEMALE; FIBROCYSTIC BREAST DISEASE; GROWTH SUBSTANCES; HUMANS; INHIBINS;

EID: 0032771674     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410190     Document Type: Article

References (18)

1. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T et al. Chemical and biochemical characterization of the inhibin family of protein hormones. Recent Progress in Hormone Research 1988 44 1-34.
2. Ueno N, Nishimatsu S & Murakami K. Activin as a cell differentiation factor. Progress in Growth Factor Research 1990 2 113-124.
3. Meunier H, Rivier C, Evans RM & Vale W. Gonadal and extragonadal expression of inhibin α, βA, and βB subunits in various tissues predicts diverse functions. Proceedings of the National Academy of Sciences of the USA 1988 85 247-251.
4. Burger HG. Inhibin as a tumor marker. Clinical Endocrinology 1994 41 151-153.
5. Yohkaiichiya T, Fudaya T, Hoshial H, Yajima A & de Kretser DM. Inhibin, a new circulating marker in nydatiform mole. British Medical Journal 1989 298 1684-1686.
6. Petraglia F, Luisi S, Pautier P, Sabourin JC, Rey R, Lhomme C & Bidart JM. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 1029-1032.
7. Di Simone N, Crowley WF, Wang QI-FA & Scheyer AL. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 1996 137 486-494.
8. Alexander JM, Swearingen B, Tindall GT & Klibanski A. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. Journal of Clinical Endocrinology and Metabolism 1995 80 147-152.
9. Petraglia F, Florio P, Luisi S, Gallo R, Garducci A, Viganò P et al. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. Journal of Clinical Endocrinology and Metabolism 1998 83 1194-1200.
10. Harada H, Shintani Y, Sakamoto M, Shitsukawa K & Saito S. Serum immunoreactive activin A in normal subjects and patients with various diseases. Journal of Clinical Endocrinology and Metabolism 1996 81 2125-2130.
11. Robinson GW & Hennighausen L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 1997 124 2701-2708.
12. Liu QY, Niranjan B, Gomes JJ, Davies D, Coombes RC & Buluwela L. Inhibitory effects of activin on growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Research 1996 56 1155-1163.
13. de Winter JP, Roelen AJ, ten Dijke P, van der Burg B & van den Eijnden-van Raaij AJ. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inibition and transcriptional response in breast tumor cells. Oncogene 1997 14 1891-1899.
14. Vaughan JM, Rivier J, Corrigan AZ, McClintock R, Campen CA, Jolley D et al. Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods in Enzymology 1989 168 588-601.
15. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mether JP et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1996 81 1401-1405.
16. Petraglia F, Hartmann B, Luisi S, Florio P, Santuz M, Kirchengast S et al. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea. Fertility and Sterility 1998 70 907-912.
17. Kalkhoven E, Roelen BA, de Winter JP, Mummery CL, van den Eijnden-van Raaij AJ, van der Saag PT et al. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth and Differentiation 1995 6 1151-1161.
18. Ho TY & Russo IH. Polypeptide pattern of human breast epithelial cells following human chorionic gonadotropin (hCG) treatment. Electrophoresis 1994 15 746-750.